A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT...

por Pagliarini, Sergio, Beatty, Stephen, Lipkova, Blandina, Perez-Salvador Garcia, Eduardo, Reynders, Stefaan, Gekkieva, Margarita, Si Bouazza, Abdelkader, Pilz, Stefan
Publicado 2014